ALPS Advisors’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-67,211
| Closed | -$179K | – | 1046 |
|
|
2022
Q1 | $179K | Sell |
67,211
-8,302
| -11% | -$22.1K | ﹤0.01% | 809 |
|
|
2021
Q4 | $327K | Sell |
75,513
-4,340
| -5% | -$18.8K | ﹤0.01% | 811 |
|
|
2021
Q3 | $406K | Sell |
79,853
-5,776
| -7% | -$29.4K | ﹤0.01% | 538 |
|
|
2021
Q2 | $542K | Buy |
85,629
+2,000
| +2% | +$12.7K | ﹤0.01% | 506 |
|
|
2021
Q1 | $646K | Buy |
83,629
+136
| +0.2% | +$1.05K | 0.01% | 463 |
|
|
2020
Q4 | $547K | Buy |
+83,493
| New | +$547K | 0.01% | 482 |
|
|
2020
Q2 | – | Sell |
-82,601
| Closed | -$634K | – | 791 |
|
|
2020
Q1 | $634K | Sell |
82,601
-9,632
| -10% | -$73.9K | 0.01% | 402 |
|
|
2019
Q4 | $766K | Buy |
+92,233
| New | +$766K | 0.01% | 423 |
|